Stocks and Investing Stocks and Investing
Thu, November 2, 2017

David Lewis Maintained (ZBH) at Buy with Decreased Target to $136 on, Nov 2nd, 2017


Published on 2024-10-26 00:23:42 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $146 to $136 on, Nov 2nd, 2017.

David has made no other calls on ZBH in the last 4 months.



There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Friday, July 28th, 2017


These are the ratings of the 3 analyists that currently disagree with David


  • Jennie Tsai of "Gabelli & Co." Initiated at Strong Buy on, Thursday, August 24th, 2017
  • Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Friday, July 28th, 2017
  • Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017
Contributing Sources